Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Nchi: Singapoo

Lugha: Kiingereza

Chanzo: HSA (Health Sciences Authority)

Inapatikana kutoka:

FERRING PHARMACEUTICALS PRIVATE LIMITED

Darasa:

Class D medical device

Viwandani na:

Bio-Technology General (Israel) Ltd.

Eneo la matibabu:

Orthopaedics

Matibabu dalili:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Bidhaa muhtasari:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Idhini ya tarehe:

2017-04-28